1. Home
  2. MPB vs PHAR Comparison

MPB vs PHAR Comparison

Compare MPB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid Penn Bancorp

MPB

Mid Penn Bancorp

HOLD

Current Price

$32.45

Market Cap

856.0M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.67

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPB
PHAR
Founded
1868
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
856.0M
1.2B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
MPB
PHAR
Price
$32.45
$12.67
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$37.00
$38.33
AVG Volume (30 Days)
106.5K
10.4K
Earning Date
04-21-2026
05-07-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
N/A
N/A
Revenue This Year
$30.95
$10.04
Revenue Next Year
$9.45
$2.51
P/E Ratio
$90.63
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$9.54
52 Week High
$35.22
$21.34

Technical Indicators

Market Signals
Indicator
MPB
PHAR
Relative Strength Index (RSI) 48.99 31.19
Support Level $30.66 $11.43
Resistance Level $34.88 $17.41
Average True Range (ATR) 0.80 0.53
MACD 0.01 -0.09
Stochastic Oscillator 50.90 15.28

Price Performance

Historical Comparison
MPB
PHAR

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: